STAT
JANUARY 13, 2025
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5
Pharmaceutical Technology
JUNE 15, 2023
Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
“At BUSPH, we have been working with our VA colleagues to look at PTSD symptom improvement in routine care using medical records for several years,” said Jaimie Gradus, Associate Professor of Epidemiology at BUSPH and co-principal investigator on the study.
Pharmacy Is Right For Me
APRIL 4, 2023
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! Another unique aspect of this model is that all interprofessional team members can access and document within a universal electronic medical record (EPIC).
Syner-G
JULY 7, 2023
Future growth will be driven by factors that include payers mandating the use of such diagnostics, increased understanding of drug safety, advancements in quality of diagnostic testing, and more informed and proactive consumers. Drug development companies must embrace new technology.
pharmaphorum
JUNE 18, 2021
Patient recruitment and retention in clinical trials have long been significant challenges for drug developers. As a result, trawling through a physician’s notes in electronic medical records (EMRs), pathology reports, and other medical data to determine the most important insights could take human beings months.
pharmaphorum
OCTOBER 11, 2022
Therefore, to help contextualise study findings, external comparator arms (ECAs) can be employed, which compile data from external sources, such as patient registries and other medical records. In the general case, RCTs are the optimal approach to clinical research and drug development. Discussion.
Expert insights. Personalized for you.
323 
Let's personalize your content